Top section
Top section
Offer came as markets recovered and volatility fell
Submarine mast maker's IPO raised €132.8m
Broaching the delicate subject with your boss of being asked to keep too many plates spinning
More articles
More articles
More articles
-
Hong Kong’s Securities and Futures Commission (SFC) is planning to bring in sweeping changes to rules governing equity and bond deals, requiring syndicate teams to be fixed earlier and fee structures to be disclosed. The moves have divided bankers. Jonathan Breen and Morgan Davis report. -
New Horizon Health, a medical device manufacturer, has scooped up HK$2.04bn ($263.4m) from its IPO after strong institutional investor demand pushed pricing up to the top of the marketed range.
-
Société Générale and Natixis both endured a difficult 2020 in their markets business, but in the fourth quarter their equities divisions managed to pull off a brighter performance.
-
UK biotech firms are continuing to reap the benefits from US listings. On Tuesday Autolus Therapeutics, an early stage biopharma firm backed by Syncona Investments, became the latest UK Biotech firm to raise capital on the US Nasdaq in a $100m transaction. The deal shows the continued advantages for early stage European biotech firms in having a US listing.
-
IVC Evidensia, Europe’s largest veterinary care provider, backed by Swedish private equity firm EQT, has announced the results of a private equity capital raising on Tuesday. The company was reported to be considering a London listing this year, but this new raise might delay that listing.
-
Apollo Global Management has exited Watches of Switzerland, the UK luxury watch retailer, having sold the last of its shares via an accelerated bookbuild.
Sub-sections
shared comment list
